
Advancing Tuberculosis Research: Genemind Biosciences’ Impact on Drug-Resistant TB
Genemind Biosciences is at the forefront of tuberculosis (TB) research, particularly in the critical area of drug-resistant TB (DR-TB). The company’s innovative technologies and solutions are driving advancements in the identification and characterization of drug resistance in TB infections, making significant strides in the fight against this challenging global health